Compare · STE vs XPEL
STE vs XPEL
Side-by-side comparison of STERIS plc (Ireland) (STE) and XPEL Inc. (XPEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- STE operates in Health Care, while XPEL operates in Industrials - the two are in different parts of the market.
- STE is the larger of the two at $21.87B, about 17.9x XPEL ($1.22B).
- Over the past year, STE is down 7.4% and XPEL is up 27.0% - XPEL leads by 34.4 points.
- STE has been more active in the news (4 items in the past 4 weeks vs 3 for XPEL).
- STE has more recent analyst coverage (17 ratings vs 3 for XPEL).
- Company
- STERIS plc (Ireland)
- XPEL Inc.
- Price
- $222.35-0.91%
- $43.82-1.15%
- Market cap
- $21.87B
- $1.22B
- 1M return
- +6.90%
- -1.41%
- 1Y return
- -7.45%
- +27.00%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 4
- 3
- Recent ratings
- 17
- 3
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Latest STE
- SEC Form 8-K filed by STERIS plc (Ireland)
- Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
- STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
- SEC Form 4 filed by STERIS plc (Ireland)
- STERIS to Present at the Morgan Stanley Healthcare Conference
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
Latest XPEL
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- SEC Form 4 filed by XPEL Inc.
- SEC Form 4 filed by XPEL Inc.
- Director North John F converted options into 441 shares, increasing direct ownership by 4% to 10,716 units (SEC Form 4)
- Director Bogart Stacy L converted options into 441 shares, increasing direct ownership by 5% to 8,907 units (SEC Form 4)
- 34 Miles Out to Sea, Nowhere to Hide from the Sun: Tint World® and XPEL Team Up to Protect Historic Frying Pan Shoals Tower
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- XPEL and Will Castro Return for Season 2 of 'Unique Academy USA,' Expanding Reach of Transformative Automotive Career Program
- SEC Form 10-Q filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits